157 related articles for article (PubMed ID: 38157715)
1. Effect of metformin on the risk of depression: A systematic review and meta-regression of observational studies.
Zhang Y; Chan VK; Chan SSM; Chan EWY; Lee CH; Wong IC; Li X
Asian J Psychiatr; 2024 Feb; 92():103894. PubMed ID: 38157715
[No Abstract] [Full Text] [Related]
2. [Metformin and type-2 diabetes mellitus].
Mata Cases M
Aten Primaria; 2008 Mar; 40(3):147-53. PubMed ID: 18373928
[No Abstract] [Full Text] [Related]
3. Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus.
Guo M; Mi J; Jiang QM; Xu JM; Tang YY; Tian G; Wang B
Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):650-6. PubMed ID: 24862430
[TBL] [Abstract][Full Text] [Related]
4. Summaries for patients. Metformin for patients with type 2 diabetes mellitus.
Ann Intern Med; 2002 Jul; 137(1):I50. PubMed ID: 12093266
[No Abstract] [Full Text] [Related]
5. The effect of metformin on esophageal cancer risk in patients with type 2 diabetes mellitus: a systematic review and meta‑analysis.
Wu HD; Zhang JJ; Zhou BJ
Clin Transl Oncol; 2021 Feb; 23(2):275-282. PubMed ID: 32507907
[TBL] [Abstract][Full Text] [Related]
6. The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta-analysis.
Xiao K; Liu F; Liu J; Xu J; Wu Q; Li X
J Clin Pharm Ther; 2020 Aug; 45(4):783-792. PubMed ID: 32406122
[TBL] [Abstract][Full Text] [Related]
7. Metformin: diamonds are forever.
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
[TBL] [Abstract][Full Text] [Related]
8. Comparison of repaglinide and metformin versus metformin alone for type 2 diabetes: a meta-analysis of randomized controlled trials.
Yin J; Deng H; Qin S; Tang W; Zeng L; Zhou B
Diabetes Res Clin Pract; 2014 Sep; 105(3):e10-5. PubMed ID: 25005849
[TBL] [Abstract][Full Text] [Related]
9. Repositioning of diabetes treatments for depressive symptoms: A systematic review and meta-analysis of clinical trials.
Moulton CD; Hopkins CWP; Ismail K; Stahl D
Psychoneuroendocrinology; 2018 Aug; 94():91-103. PubMed ID: 29775878
[TBL] [Abstract][Full Text] [Related]
10. Repurposing Metformin for Cardiovascular Disease.
Rena G; Lang CC
Circulation; 2018 Jan; 137(5):422-424. PubMed ID: 29378754
[No Abstract] [Full Text] [Related]
11. Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis.
Tang GH; Satkunam M; Pond GR; Steinberg GR; Blandino G; Schünemann HJ; Muti P
Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):627-635. PubMed ID: 29618465
[No Abstract] [Full Text] [Related]
12. Association between metformin and vitamin B
Chapman LE; Darling AL; Brown JE
Diabetes Metab; 2016 Nov; 42(5):316-327. PubMed ID: 27130885
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of dipeptidyl peptidase-4 inhibitors and metformin as initial combination therapy and as monotherapy in patients with type 2 diabetes mellitus: a meta-analysis.
Wu D; Li L; Liu C
Diabetes Obes Metab; 2014 Jan; 16(1):30-7. PubMed ID: 23803146
[TBL] [Abstract][Full Text] [Related]
14. [Characteristic of metformin for treatment of impaired glucose tolerance].
Ishida W; Satoh J
Nihon Rinsho; 2005 Feb; 63 Suppl 2():433-7. PubMed ID: 15779418
[No Abstract] [Full Text] [Related]
15. Metformin: an update.
Kirpichnikov D; McFarlane SI; Sowers JR
Ann Intern Med; 2002 Jul; 137(1):25-33. PubMed ID: 12093242
[TBL] [Abstract][Full Text] [Related]
16. Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies.
Liang H; Ding X; Li L; Wang T; Kan Q; Wang L; Sun T
Crit Care; 2019 Feb; 23(1):50. PubMed ID: 30777119
[TBL] [Abstract][Full Text] [Related]
17. [Role of metformin in diabetes treatment--is metformin falling from grace?].
van Dijk PR; Landman GW; Bilo HJ
Ned Tijdschr Geneeskd; 2012; 156(43):A5297. PubMed ID: 23095485
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of metformin alone or as an add-on therapy to insulin in pregnancy with GDM or T2DM: A systematic review and meta-analysis of 21 randomized controlled trials.
He K; Guo Q; Ge J; Li J; Li C; Jing Z
J Clin Pharm Ther; 2022 Feb; 47(2):168-177. PubMed ID: 34363237
[TBL] [Abstract][Full Text] [Related]
19. [Advantages of the use of metformin in patients with impaired uric acid metabolism].
Eliseev MS; Panevin TS; Zhelyabina OV; Nasonov EL
Ter Arkh; 2021 May; 93(5):71520. PubMed ID: 36286721
[TBL] [Abstract][Full Text] [Related]
20. Metformin and health outcomes: An umbrella review of systematic reviews with meta-analyses.
Li X; Celotto S; Pizzol D; Gasevic D; Ji MM; Barnini T; Solmi M; Stubbs B; Smith L; López Sánchez GF; Pesolillo G; Yu Z; Tzoulaki I; Theodoratou E; Ioannidis JPA; Veronese N; Demurtas J
Eur J Clin Invest; 2021 Jul; 51(7):e13536. PubMed ID: 33709434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
